| Mrs Denise Lee Falardeau, NP | |
|
1500 Duarte Rd, Machris 2101, Duarte, CA 91010-3012 | |
| (626) 471-9200 | |
| (626) 218-0188 |
| Full Name | Mrs Denise Lee Falardeau |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1500 Duarte Rd, Duarte, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033512595 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loma Linda University Medical Center | Loma linda, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faculty Physicians And Surgeons Of Llusm | 1153227814 | 1053 |
News Archive
Senior internal medicine residents who are trained in critical resuscitation skills on patient simulators become more skilled than residents who undergo traditional training, according to new research.
biospace med announced today that a 50-patient clinical study published in the current issue of the peer-reviewed medical journal Spine demonstrates that the Company's ultra-low-dose 2D/3D imaging system, EOS, shows "significantly better" image quality compared to a CR (Computed Radiography) x-ray system while "substantially reducing (a) patient's (radiation) dose exposure" by up to 9 times (89%) compared to CR imaging.
Two University of Kansas professors were prime movers behind an internet-based health promotion initiative launched by the Pan American Health Organization (PAH0), the regional arm of the United Nations World Health Organization (WH0), on November 7 in Washington, D.C.
Data from the Treating to New Targets (TNT) trial presented today at the American Society of Hypertension's Twenty Fourth Annual Scientific Meeting (ASH 2009) show that low blood pressure levels may lead to increased risk of cardiovascular events, including heart attack and stroke. These data supplement previous findings from the TNT trial of atorvastatin showing aggressive LDL cholesterol-lowering reduced cardiovascular events.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.
› Verified 7 days ago
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205009917 PECOS PAC ID: 1153227814 Enrollment ID: O20031211000981 |
News Archive
Senior internal medicine residents who are trained in critical resuscitation skills on patient simulators become more skilled than residents who undergo traditional training, according to new research.
biospace med announced today that a 50-patient clinical study published in the current issue of the peer-reviewed medical journal Spine demonstrates that the Company's ultra-low-dose 2D/3D imaging system, EOS, shows "significantly better" image quality compared to a CR (Computed Radiography) x-ray system while "substantially reducing (a) patient's (radiation) dose exposure" by up to 9 times (89%) compared to CR imaging.
Two University of Kansas professors were prime movers behind an internet-based health promotion initiative launched by the Pan American Health Organization (PAH0), the regional arm of the United Nations World Health Organization (WH0), on November 7 in Washington, D.C.
Data from the Treating to New Targets (TNT) trial presented today at the American Society of Hypertension's Twenty Fourth Annual Scientific Meeting (ASH 2009) show that low blood pressure levels may lead to increased risk of cardiovascular events, including heart attack and stroke. These data supplement previous findings from the TNT trial of atorvastatin showing aggressive LDL cholesterol-lowering reduced cardiovascular events.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.
› Verified 7 days ago
| Entity Name | City Of Hope Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871886366 PECOS PAC ID: 3779751656 Enrollment ID: O20110720000244 |
News Archive
Senior internal medicine residents who are trained in critical resuscitation skills on patient simulators become more skilled than residents who undergo traditional training, according to new research.
biospace med announced today that a 50-patient clinical study published in the current issue of the peer-reviewed medical journal Spine demonstrates that the Company's ultra-low-dose 2D/3D imaging system, EOS, shows "significantly better" image quality compared to a CR (Computed Radiography) x-ray system while "substantially reducing (a) patient's (radiation) dose exposure" by up to 9 times (89%) compared to CR imaging.
Two University of Kansas professors were prime movers behind an internet-based health promotion initiative launched by the Pan American Health Organization (PAH0), the regional arm of the United Nations World Health Organization (WH0), on November 7 in Washington, D.C.
Data from the Treating to New Targets (TNT) trial presented today at the American Society of Hypertension's Twenty Fourth Annual Scientific Meeting (ASH 2009) show that low blood pressure levels may lead to increased risk of cardiovascular events, including heart attack and stroke. These data supplement previous findings from the TNT trial of atorvastatin showing aggressive LDL cholesterol-lowering reduced cardiovascular events.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.
› Verified 7 days ago
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508255175 PECOS PAC ID: 1153227814 Enrollment ID: O20160216002196 |
News Archive
Senior internal medicine residents who are trained in critical resuscitation skills on patient simulators become more skilled than residents who undergo traditional training, according to new research.
biospace med announced today that a 50-patient clinical study published in the current issue of the peer-reviewed medical journal Spine demonstrates that the Company's ultra-low-dose 2D/3D imaging system, EOS, shows "significantly better" image quality compared to a CR (Computed Radiography) x-ray system while "substantially reducing (a) patient's (radiation) dose exposure" by up to 9 times (89%) compared to CR imaging.
Two University of Kansas professors were prime movers behind an internet-based health promotion initiative launched by the Pan American Health Organization (PAH0), the regional arm of the United Nations World Health Organization (WH0), on November 7 in Washington, D.C.
Data from the Treating to New Targets (TNT) trial presented today at the American Society of Hypertension's Twenty Fourth Annual Scientific Meeting (ASH 2009) show that low blood pressure levels may lead to increased risk of cardiovascular events, including heart attack and stroke. These data supplement previous findings from the TNT trial of atorvastatin showing aggressive LDL cholesterol-lowering reduced cardiovascular events.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Denise Lee Falardeau, NP Po Box 512185, Los Angeles, CA 90051-0185 Ph: (626) 775-3514 | Mrs Denise Lee Falardeau, NP 1500 Duarte Rd, Machris 2101, Duarte, CA 91010-3012 Ph: (626) 471-9200 |
News Archive
Senior internal medicine residents who are trained in critical resuscitation skills on patient simulators become more skilled than residents who undergo traditional training, according to new research.
biospace med announced today that a 50-patient clinical study published in the current issue of the peer-reviewed medical journal Spine demonstrates that the Company's ultra-low-dose 2D/3D imaging system, EOS, shows "significantly better" image quality compared to a CR (Computed Radiography) x-ray system while "substantially reducing (a) patient's (radiation) dose exposure" by up to 9 times (89%) compared to CR imaging.
Two University of Kansas professors were prime movers behind an internet-based health promotion initiative launched by the Pan American Health Organization (PAH0), the regional arm of the United Nations World Health Organization (WH0), on November 7 in Washington, D.C.
Data from the Treating to New Targets (TNT) trial presented today at the American Society of Hypertension's Twenty Fourth Annual Scientific Meeting (ASH 2009) show that low blood pressure levels may lead to increased risk of cardiovascular events, including heart attack and stroke. These data supplement previous findings from the TNT trial of atorvastatin showing aggressive LDL cholesterol-lowering reduced cardiovascular events.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.
› Verified 7 days ago
Miss Janice Mae Villegas, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2236 Park Rose Ave, Duarte, CA 91010 Phone: 626-475-4663 | |
Mrs. Erica H Chin, RN, NP, MS Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1500 East Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 Fax: 626-471-7155 | |
Maria Elena Dela Rosa, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Tim Nguyen, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Miss Gabriela Claudia Medrano, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Rhodelynn Bonner, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 Fax: 626-301-8256 |